B4GALT5 and breast carcinoma: In 2020, Tang et al. verified that B4GALT5 modulates the stemness of breast cancer through glycosylation modification to stabilize Frizzled-1 and activate Wnt/β-catenin signalling independent of its cell surface location [59].